Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Peptidoglycan recognition protein 1-Heat shock protein 70 complex (Tag7-Hsp70) is a stable, bi-molecular cytotoxic aggregate produced by the innate immune system, specifically by natural killer (NK) cells and monocytes [Sashchenko et al., 2004, J Biol Chem]. This complex plays a critical role in anti-tumor immunity by selectively inducing cell death in various malignant cell lines while sparing most normal cells [Yashin et al., 2015, J Biol Chem]. Its primary mechanism of action involves high-affinity binding to the Tumor Necrosis Factor Receptor 1 (TNFR1) on the target cell surface [Dukhanina et al., 2015, Cell Cycle]. Unlike the native TNF-alpha ligand, which can trigger both pro-survival (NF-kB) and pro-apoptotic pathways, the Tag7-Hsp70 complex is specialized to activate the programmed cell death machinery, including both caspase-dependent apoptosis and RIPK1-mediated necroptosis [Sharapova et al., 2021, Cells]. Because it can bypass certain resistance mechanisms in cancer cells, such as those involving the inhibition of traditional apoptotic pathways, it is being investigated as a potential therapeutic agent or a template for novel cancer immunotherapies [Sashchenko et al., 2007, IUBMB Life]. The complex's ability to modulate TNFR1 signaling makes it a unique tool for studying receptor-mediated cell death and a target for developing biologics that mimic its cytotoxic activity.
The complex binds with high affinity to the extracellular domain of the Tumor Necrosis Factor Receptor 1 (TNFR1), inducing a specific conformational change that recruits adapter proteins such as TRADD and FADD to form the death-inducing signaling complex (DISC), which subsequently activates caspase-dependent apoptosis or RIPK1-mediated necroptosis in tumor cells [Yashin et al., 2015, J Biol Chem; Sharapova et al., 2021, Cells].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan recognition protein 1-Heat shock protein 70 complex (Tag7-Hsp70) (Tag7-Hsp70).